Your browser doesn't support javascript.
loading
Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer.
Woodward, Alexis; Southard, Benjamin; Chakraborty, Sampurna; Bailey, Aaron O; Faria, Gabriela N F; McKernan, Patrick; Razaq, Wajeeha; Harrison, Roger G.
Afiliação
  • Woodward A; Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA.
  • Southard B; Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA.
  • Chakraborty S; Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA.
  • Bailey AO; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
  • Faria GNF; AbCellera Biologics Inc., Vancouver, BC, Canada.
  • McKernan P; School of Sustainable Chemical, Biological, and Materials Engineering, University of Oklahoma, Norman, OK, USA.
  • Razaq W; Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA.
  • Harrison RG; Stephenson Cancer Center, Oklahoma City, OK, USA.
Mol Biomed ; 5(1): 7, 2024 02 19.
Article em En | MEDLINE | ID: mdl-38369647

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Ado-Trastuzumab Emtansina Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Ado-Trastuzumab Emtansina Idioma: En Ano de publicação: 2024 Tipo de documento: Article